1. Tikofsky RS, Trembath LA, Voslar AM. Radiopharmaceuticals for brain imaging: the technologist’s perspective. J Nucl Med Technol. 1993;21(2):57–60.
2. Menzel C, Steidele S, Grünwald F, Hufnagel A, Pavics L, Elger CE, et al. Evaluation of technetium-99m-ECD in childhood epilepsy. J Nucl Med. 1996;37(7):1106–12.
3. Iida H, Akutsu T, Endo K, Fukuda H, Inoue T, Ito H, et al. A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab. 1996;16(5):781–93.
4. Greenberg JH, Kushner M, Rango M, Alavi A, Reivich M. Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography. J Nucl Med. 1990;31(8):1364–9.
5. Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by N-isopropyl-p[I-123]iodo amphetamine (IMP) tomography. J Nucl Med. 1982;23:196–203.